1 insider bought €6,251 of shares over the last 90 days, the latest by 소지성, filed 03 Sept 2026.
아미코젠: what insiders have been doing
This page follows insider dealings at 아미코젠 as filed with DART (FSS), a company from the Chemicals sector. Between 2 November 2025 and 2 November 2026, 5 insiders published 9 filings.
The flow runs one way only: 4 insiders bought (7 purchases totalling €108k) and nobody sold on the market. The totals do not cover 6 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. On the buying side, the filings list 3 board members among the declarants. The largest single trade was a purchase of €108k by 소지성, published on 4 May 2026, equal to 0.26% of the market capitalisation.
Compared with its exchange (2,655 companies, median 7 filings), a count of 9 filings is above the norm. Our records for 아미코젠 go back to 2021, with 38 purchases and no sales on the open market in total.
The latest purchase dates back some time: it was published 68 days ago, on 3 September 2026. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. Until a filing is published, the market cannot know about the trade.
Other companies in the same sector with recent insider buying flagged by our signals: Symrise AG and Titan. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- -45.9%Entry ₩1,692 · Close 30 Oct 2026 ₩916
- -45.9%Entry ₩1,692 · Close 30 Oct 2026 ₩916
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 10,000 sharesShareKRXDART:20260903000054Canonical exit: 2 Dec 2026 (T+90)
- 4,300 sharesShareKRXDART:20260810000130Canonical exit: 8 Nov 2026 (T+90)
- 62,435 sharesKRXDART:20260504000425Canonical exit: 26 Jul 2026 (T+90)
- 100,000 shares@ ₩1,862.000.26% mcap100.0% of flowShareKRXDART:20260504000418Canonical exit: 26 Jul 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 109 sharesShareKRXDART:20260303002760Canonical exit: 27 May 2026 (T+90)
- 435 sharesShareKRXDART:20260303002477Canonical exit: 27 May 2026 (T+90)
- 4,000 sharesShareKRXDART:20260227007564Canonical exit: 28 May 2026 (T+90)
- 2,960,541 sharesKRXDART:20250423000506Canonical exit: 15 Jul 2025 (T+90)
- ●Executives0DART
- 220,000 sharesShareKRXDART:20250312000118Canonical exit: 10 Jun 2025 (T+90)
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- ●Executives0DART
- 5,514,582 sharesKRXDART:20241202000017Canonical exit: 2 Mar 2025 (T+90)
- 0KRXDART:20240930000560
- 0KRXDART:20240905000301
- 9,777 sharesKRXDART:20240808000414Canonical exit: 30 Oct 2024 (T+90)
- ShareKRXDART:20240808000397Canonical exit: 30 Oct 2024 (T+90)
- 0KRXDART:20240731000565
- ShareKRXDART:20240709000236Canonical exit: 11 Mar 2024 (T+90)
- 39,177 sharesKRXDART:20240702000004Canonical exit: 29 Sept 2024 (T+90)
25 of 74 declarations
About 아미코젠
Amicogen is a company specializing in the chemistry and materials sector, listed on the XKRX market. It focuses on the development of biotechnological and enzymatic solutions.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
